Abstract Despite Polycystic Ovary Syndrome (PCOS) is a very prevalent disorder among women of reproductive age, there is widespread agreement that until now, no pharmacological options are available to tackle the entire spectrum of clinical manifestations encountered in the clinical practice
The results of such studies, including those of large sample size using national cohort data, is still conflicting
This may result in shame, self-consciousness, or even refusal to wear specific garments or engage in social events
Metformin improves insulin sensitivity and liver function, producing modest indirect weight loss
Because even as branded drugs become more available and potentially cheaper, the same coverage restrictions, BMI cutoffs, and off-label barriers remain